A cross-border investment vehicle holds a minority stake in a US-headquartered technology company. A routine portfolio review flags that one of the technology company's key customers appears on BIS's Entity List. Simultaneously, the investment target itself has been placed under a denial order. The fund's legal team faces a single, time-sensitive question: how do we exit this position without committing a fresh export-control violation in the process of divesting?
Divesting a sanctioned interest under BIS / EAR is a structured legal process governed by the Export Administration Regulations administered by the Bureau of Industry and Security. The divestiture itself can constitute a "transfer" or a "release" of controlled technology, triggering fresh licence requirements under the EAR (the Export Administration Regulations, the primary US dual-use export-control instrument). Handled without counsel, an exit transaction can compound rather than resolve the exposure.
This page sets out the governing regime, the divestiture decision sequence, the cross-border complications that arise when EU, UK, or UN restrictions also apply, the risk flags that require immediate escalation, and how Calder & Vance provides legal support throughout the process. As of January 2026, BIS has continued to expand the Entity List and tighten end-use controls; businesses holding or seeking to exit restricted positions face heightened scrutiny at every stage.
What does BIS / EAR control and why does it reach a divestiture?
BIS / EAR controls govern the export, re-export, and in-country transfer of US-origin items – including goods, software, and technology – on the Commerce Control List (CCL, the schedule of controlled items each assigned an ECCN, or Export Control Classification Number). A divestiture that transfers technology, source code, or controlled goods as part of the transaction falls squarely within that perimeter.
Ownership of an interest in a restricted entity is not, in itself, an EAR violation. The violation risk arises at the moment of action: when controlled technology is shared with a buyer during due diligence, when goods move as part of a carve-out, or when the transaction documents grant a buyer access to controlled data. Each of those steps can constitute an unauthorised "release" to a foreign national or an unauthorised export to a restricted destination.
BIS also has extraterritorial reach through the foreign direct product rule (FDPR, the rule treating foreign-made items that are the direct product of certain US technology or equipment as subject to the EAR). A European acquirer of a US technology stake who plans to direct the acquired entity's production toward a restricted end-user can find that the acquisition itself triggers FDPR obligations even before closing. In our cross-border practice, clients routinely underestimate how far US export-control jurisdiction extends beyond US borders.
What is the legal basis and who is the governing authority?
The legal basis for BIS / EAR controls is the Export Control Reform Act and its implementing regulations under the EAR. BIS, a division of the US Department of Commerce, administers the CCL, issues licences, maintains the Entity List and Denied Persons List, and brings administrative enforcement actions. The Department of Justice handles criminal export-control matters.
Three instruments shape a divestiture under BIS / EAR. First, the CCL determines whether the underlying technology or goods require a licence for any transfer. Second, the Entity List identifies counterparties for whom a licence requirement applies (a presumption of denial in most cases), meaning the licence requirement can attach to the buyer, the seller, or the restricted target company. Third, a Temporary Denial Order (a TDO, a time-limited BIS order suspending a party's export privileges) can freeze a company's ability to participate in any export transaction – including a divestiture – for the duration of the order.
The position above describes the default rule. Your specific facts – the ECCN of the controlled items, the nationality of the buyer, the end-use certification available, and any pending BIS correspondence – change the analysis materially.
For a confidential review of your divestiture exposure under BIS / EAR, contact Calder & Vance at info@caldervance.com.
What is the divestiture decision sequence under BIS / EAR?
The sequence runs in five ordered steps; skipping any step risks creating fresh liability in the course of exiting the original exposure.
- Classify the controlled items. Before any buyer is approached, every item of technology, software, and goods held by or within the target company must be classified against the CCL. Items without an ECCN may be EAR99 (the catch-all classification for items subject to the EAR but not listed on the CCL, which typically require no licence for export to non-embargoed destinations). Items with an ECCN carry control codes that map to specific licence requirements by destination and end-use.
- Screen the proposed buyer. The buyer and every entity in its ownership chain must be screened against the Entity List, the Denied Persons List, the SDN List (OFAC's list of Specially Designated Nationals and blocked persons), and the BIS Unverified List. A buyer connected to a restricted end-user can convert a compliant divestiture into a prohibited transfer.
- Assess the due-diligence data room. Any controlled technology shared with a prospective buyer during due diligence constitutes a deemed export or re-export if the recipient is a foreign national or a foreign entity. A clean data room – one that isolates controlled technology pending licence clearance – is not optional; it is a legal requirement.
- Determine whether a BIS licence is required. If the buyer, the destination, or the end-use triggers a licence requirement, a specific licence application must be filed with BIS before closing. The application must accurately describe the technology, the buyer, and the intended use. Filing timelines are not fixed by statute but are typically measured in weeks to months depending on the complexity of the case and the sensitivity of the items.
- Document the end-use assurances. BIS expects exporters to obtain and retain end-use certifications for controlled items. In a divestiture, this means the transaction documents must include enforceable representations from the buyer about the end-use of the acquired technology. Record-keeping obligations run for a defined period after closing; verify the current requirement before relying on any specific figure.
We regularly advise on each stage of this sequence, including building the data-room protocol, managing the BIS licence application, and negotiating the end-use provisions in the sale and purchase agreement.
How do EU, UK, and UN controls interact with a BIS / EAR divestiture?
A BIS / EAR divestiture rarely operates in a single-regime vacuum. Most cross-border technology divestitures also engage EU dual-use controls, UK export licensing, and potentially UN Security Council measures – and the regimes do not always point in the same direction.
Under EU dual-use rules (the relevant Council Regulation, which applies to items listed in the EU dual-use annex), a European seller or intermediary participates in a divestiture that involves an EU-origin item may need a separate authorisation from the relevant EU member-state authority. The EU list overlaps substantially with the CCL but is not identical. Items that are EAR99 may still be controlled under EU rules, and vice versa. Where both regimes apply, the stricter prohibition governs.
The UK Export Control Order and ECJU licensing apply to UK-origin technology and to transactions routed through the United Kingdom. Since the UK is no longer subject to EU dual-use regulations, a divestiture involving UK-headquartered entities must be analysed separately against the UK strategic export-control lists. OFSI's financial-sanctions rules also apply if any party to the divestiture is a UK-designated person or is subject to a UK asset freeze.
At the UN level, Security Council measures adopted under Chapter VII of the UN Charter impose binding obligations on all member states. A divestiture that involves an entity subject to UN measures requires analysis of the relevant Security Council committee's position. National licences do not override UN measures.
In our experience, the interaction between BIS entity controls and EU or UK end-use restrictions is the most common source of surprise in cross-border technology divestitures. A transaction cleared at the US level may still require EU or UK authorisation; a party that proceeds on US clearance alone can face enforcement action in Europe.
If a transaction has already been flagged or a filing has been refused, an early cross-regime review can preserve options that narrow with time. Contact us at info@caldervance.com to discuss the position.
What are the main risk flags in a BIS / EAR divestiture?
Five risk patterns recur across BIS / EAR divestitures handled by our practice. Each requires escalation before the transaction proceeds.
- An active Temporary Denial Order. A TDO suspends all export privileges for the named party and, potentially, for related companies. Participating in any export transaction – including a divestiture – while subject to a TDO creates fresh criminal and administrative exposure. The first step is always to confirm whether a TDO is in force and whether it can be modified.
- Technology released during preliminary due diligence. Pre-signing access to controlled technology, even under non-disclosure arrangements, constitutes a deemed export if the recipient is a foreign national. Businesses that open a data room without first classifying the contents and screening the recipients regularly create violations before the transaction is announced.
- A buyer with undisclosed government connections. End-use controls apply with heightened force when the buyer has direct or indirect connections to a foreign government or military. BIS's end-use review extends beyond the immediate buyer to the ultimate end-user; a buyer who will on-sell controlled technology to a restricted end-user converts the divestiture into a prohibited transfer.
- Inadequate chain-of-ownership mapping. The FDPR's reach depends on whether the US technology or equipment that produced a foreign item meets defined thresholds. Incomplete ownership mapping – typically in multi-layered corporate structures – means the FDPR analysis cannot be completed. A deal closed on incomplete analysis is a deal closed on guesswork.
- Failure to identify the OFAC dimension. BIS and OFAC operate parallel but distinct programmes. An entity that does not appear on the Entity List may still be blocked under OFAC rules. In our experience, teams that focus exclusively on BIS miss the OFAC layer until an OFAC compliance officer raises it – often after heads of terms have been signed.
What is the common myth about BIS / EAR and divesting restricted interests?
A persistent belief among deal teams is that once a decision to divest has been made, the export-control analysis is over. The logic runs: we are exiting the restricted position, not deepening it; therefore, US export controls cannot apply to the exit itself.
That reasoning is mistaken. The EAR does not exempt divestiture transactions from its scope. The transfer of controlled technology to a buyer – including through a data room, a technical disclosure, or the assignment of contracts involving controlled items – is an export transaction governed by the EAR regardless of the commercial purpose. The intent to divest provides no licence; only a BIS licence or an applicable licence exception provides authorisation.
We have acted for clients who proceeded on this reasoning and found themselves managing a simultaneous BIS voluntary disclosure and a delayed divestiture. The corrective work is substantially more demanding than pre-transaction classification and screening. Treating the divestiture as a clean exit from sanctions risk, rather than a transaction that must itself be structured for compliance, is the single most common avoidable error in this practice area.
How does Calder & Vance provide legal support for a BIS / EAR divestiture?
Our support covers the full divestiture lifecycle: from the initial exposure assessment through the data-room design, the BIS licence application, the transaction documentation, and the post-closing record-keeping obligations.
In a recent matter, a technology-sector fund faced an urgent divestiture from a portfolio company that had received a BIS warning letter relating to a controlled end-use. We classified the company's controlled items against the CCL, designed a tiered data-room protocol that isolated technology requiring licence clearance, and managed the BIS licence application on an expedited basis. The transaction was structured to comply with both BIS requirements and the applicable EU dual-use rules, with coordinated advice from local counsel in the EU jurisdiction. The matter closed on the scheduled timetable.
The action set we deploy in a divestiture engagement includes:
- Classifying the controlled items against the CCL and the EU and UK dual-use lists;
- Screening the buyer and ownership chain against all relevant lists (Entity List, SDN List, Denied Persons List, Unverified List, and the applicable UN list);
- Designing and implementing a compliant data-room protocol for the due-diligence process;
- Preparing and submitting the BIS licence application, including managing BIS's queries during review;
- Drafting the export-control representations, warranties, and end-use undertakings in the sale and purchase agreement;
- Advising on parallel EU, UK, and UN obligations and coordinating with local counsel where required;
- Advising on any voluntary self-disclosure obligations arising from pre-transaction releases of controlled technology.
Fixed-fee entry points are available for the initial exposure assessment and the licence-application stage. The scope and fee are agreed before work begins.
Related practices
- Correspondent banking and de-risking under OFAC – sanctions-driven account closure, de-risking analysis, and financial-institution compliance advice
- Divesting a sanctioned interest – extended guidance – supplementary analysis on complex multi-regime divestiture structures
- Divestiture and export-control documentation – transaction document review and export-control clause drafting for BIS / EAR divestitures